Literature DB >> 8418169

Infectious decay of human immunodeficiency virus type 1 in plasma.

T Moudgil1, E S Daar.   

Abstract

AIDS is caused by the human immunodeficiency virus type 1 (HIV-1). Recent methods have been developed to estimate infectious titer in various bodily fluids, including blood. However, lack of information about HIV-1 stability in blood has restricted the use of these techniques to fresh samples in immediately accessible virology laboratories. In studies of infectious virus decay, it was found that at room temperature, complete decay of infectious HIV-1 in plasma can require > 7 days. Furthermore, the stability of HIV-1 was enhanced by storage at 4 degrees C, suggesting that fresh plasma could be sent on ice to core laboratories for viral quantitation. These studies also emphasize the need for thorough decontamination of all potentially infectious material.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418169     DOI: 10.1093/infdis/167.1.210

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

2.  Human Immunodeficiency Virus (HIV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-05-09       Impact factor: 3.747

3.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Survival of human immunodeficiency virus in suspension and dried onto surfaces.

Authors:  J van Bueren; R A Simpson; P Jacobs; B D Cookson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood.

Authors:  S O'Shea; T Rostron; J E Mullen; J E Banatvala
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

6.  Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  C C Ginocchio; X P Wang; M H Kaplan; G Mulligan; D Witt; J W Romano; M Cronin; R Carroll
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.

Authors:  L Mole; D Margolis; R Carroll; J Todd; M Holodniy
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction.

Authors:  R W Coombs; D R Henrard; W F Mehaffey; J Gibson; E Eggert; T C Quinn; J Phillips
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.

Authors:  M Holodniy; L Mole; B Yen-Lieberman; D Margolis; C Starkey; R Carroll; T Spahlinger; J Todd; J B Jackson
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

10.  Quantitation of human immunodeficiency virus type 1 in breast milk.

Authors:  M K Ghosh; L Kuhn; J West; K Semrau; D Decker; D M Thea; G M Aldrovandi
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.